Papilloedema is the point: shared downstream biological mechanisms do not establish a migraine-idiopathic intracranial hypertension disease continuum.

This research commentary discusses a study about migraines and idiopathic intracranial hypertension (IIH). It focuses on papilloedema, which is swelling of the optic nerve. The authors argue that papilloedema is not the main issue. Instead, they suggest that dysregulation of intracranial pressure is a common factor. This means migraines and IIH might share similar biological mechanisms. However, the study does not support the idea that these conditions are the same. It highlights the need for more research to understand these links better. The authors believe that understanding these differences can help in developing better treatments. They emphasize the importance of distinguishing between migraines and IIH. This could lead to more effective approaches for managing both conditions. Overall, the commentary encourages ongoing investigation into the relationship between these two disorders and their underlying causes. Clinical relevance: This research emphasizes the need for accurate diagnosis and treatment strategies for migraines and IIH, potentially improving patient outcomes through tailored management approaches.